Built For Growth: Engineering Flexible And Scalable Bioprocessing Strategies

Standardizing bioprocess platforms and automation logic simplifies cross-site tech transfer and mitigates workforce constraints during program scale-up.

How Modular Workflows Are Redefining CAR T Manufacturing

Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.

Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid

Learn how rational plasmid engineering and promoter optimization can significantly improve AAV productivity while reducing plasmid burden, paving the way for more efficient and scalable viral vector manufacturing.

Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance

Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.

When High-Stakes ADC Decisions Can't Wait for More Material or Better Data

Learn how a material-sparing analytical workflow can generate reliable data, reduce dependence on calibration assays, and support faster, more confident candidate evaluation.

Modular VFlexible Aseptic Filling Lines

Modular suites with built-in contamination control streamline sterile manufacturing—supporting complex products, faster timelines, greater flexibility, less disruption, and scalable fill‑finish.

Reducing Particulate-Related Batch Risk In Bioprocessing

Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.

Residual DNA Testing Across Biotherapeutics

Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.

Breaking the Titer Ceiling: Smarter Media Design for Higher Productivity

A bottom-up, data-driven media design approach shows how targeted nutrient optimization overcomes metabolic limits to boost culture performance and titer while maintaining product quality and process consistency.

Building Scalable Non-Viral Gene-Edited Cell Therapy Processes

Rahul Purohit, Ph.D., discusses the challenges and opportunities of scaling non-viral gene-edited cell therapies, with practical guidance for balancing performance, cell quality, and manufacturing readiness.

Automating cell therapy manufacturing without redesigning established workflow

Automating Cell Therapy Manufacturing Without Redesigning Workflows

Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

How Intensified Upstream Processing Improves Scale-Up And Tech Transfer

Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.

Generate Stable High-Producing Clones In 14 Weeks

Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

Creative Chromatography Solutions For Complex Small Molecules

Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.

Using Residual DNA Quantification Data To De-Risk mAb Development

Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

The AI Advantage For Regulated Manufacturing

Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.

Viral Safety Testing In Biologics: Detecting What Current Methods Miss

Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.

Cracking Complexity: Learnings From 70+ Bispecific Antibody Programs

The goal is practical: help development teams make early decisions that balance speed, quality, and risk and support a smoother path to the clinic.

From Gene Editing To NGS-Based T Cell Characterization

Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

Efficient mAb Development With A Flexible Purification Toolkit

Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.

Faster Clones, Simpler Process: What's Changing In CHO Expression?

This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

How Solid-State Science Solves Your Toughest API Challenges

Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.

2026 Critical Manufacturing Trends Reshaping Pharma & Medical Device

Discover how modern life sciences manufacturers integrate digital threads and validated AI frameworks to eliminate operational silos, build supply chain resilience, and upskill the modern workforce.

From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System

Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.

Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing

See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic

As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.

Real-Time DAR And Concentration Measurement Without Dilution

Maintaining consistent DAR while reducing risk and variability remains a major ADC challenge. Learn how real‑time spectroscopy replaces dilution‑heavy workflows and strengthens process control.

Advancing Therapeutic Discovery With High-Throughput Electroporation

Learn how high-throughput electroporation streamlines genetic material delivery for cell therapy and drug discovery, offering speed, precision, and scalability across hard-to-transfect cell types.

The Framework For Containment In A Cleanroom

ISO classification decisions shape cleanroom design. Learn how early alignment between process needs, biosafety, and classification can reduce redesign risk while supporting scalable environments.